EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte StudieOpen access

Mixed amphetamine salts–extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial.

Kenneth M Carpenter iD, C Jean Choi, Cale Basaraba, Martina Pavlicova iD, Daniel J Brooks, Christina A Brezing iD, Adam Bisaga iD, Edward V Nunes, John J Mariani iD, Frances R Levin

Experimental and Clinical Psychopharmacology · 2024-02 · 32 (1) · 112-127

DOI: 10.1037/pha0000676 ↗

At a glance

Randomisierte kontrollierte Studie in Experimental and Clinical Psychopharmacology, 2024-02. Written by Kenneth M Carpenter and 9 co-authors. Institution: Division on Substance Use Disorders, New York State Psychiatric Institute. Major MEDLINE topics: Cocaine, Cocaine-Related Disorders, Substance-Related Disorders. Cited 7 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, National Institute on Drug Abuse.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Psychosocial interventions remain the primary strategy for addressing cocaine use disorder (CUD), although many individuals do not benefit from these approaches. Amphetamine-based interventions have shown significant promise and may improve outcomes among individuals continuing to use cocaine in the context of behavioral interventions. One hundred forty-five adults (122 males) who used cocaine a minimum of 4 days in the prior month and met the criteria for a CUD enrolled in a two-stage intervention. All participants received a computer-delivered skills intervention and contingency management for reinforcing abstinence for a 1-month period. Participants demonstrating less than 3 weeks of abstinence in the first month were randomized to receive mixed amphetamine salts-extended release (MAS-ER) or placebo (80 mg/day) for 10 weeks under double-blind conditions. All participants continued with the behavioral intervention. The primary outcome was the proportion of individuals who achieved 3 consecutive weeks of abstinence as measured by urine toxicology confirmed self-report at the study end. The proportion of participants demonstrating 3 consecutive weeks of abstinence at study end did not differ between the medication groups: MAS-ER = 15.6% (7/45) and placebo = 12.2% (5/41). Participants who received MAS-ER reported greater reductions in the magnitude of wanting cocaine, although no group differences were noted in either the perceived improvement or the frequency of wanting cocaine. Retention rates were greater for both medication groups compared to behavioral responders. Overall, augmenting a behavioral intervention with MAS-ER did not significantly increase the abstinence rate among individuals continuing to use cocaine following a month of behavioral therapy alone. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Subjects

MeSH terms (MEDLINE)

CocaineCocaine-Related DisordersSubstance-Related DisordersAdultHumansMaleAmphetamineBehavior TherapyDouble-Blind MethodSaltsTreatment OutcomeFemale

Substances

AmphetamineCocaineSalts

Authors and institutions

  • Division on Substance Use Disorders, New York State Psychiatric Institute.
  • New York State Psychiatric Institute.

ORCID profiles: Kenneth M Carpenter, Martina Pavlicova, Christina A Brezing, Adam Bisaga, John J Mariani

Funding

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Cite

APA

Carpenter, K. M., Choi, C. J., Basaraba, C., Pavlicova, M., Brooks, D. J., Brezing, C. A., Bisaga, A., Nunes, E. V., Mariani, J. J., & Levin, F. R. (2024). Mixed amphetamine salts–extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial. Experimental and Clinical Psychopharmacology, 32(1), 112-127. https://doi.org/10.1037/pha0000676

Vancouver

Carpenter KM, Choi CJ, Basaraba C, Pavlicova M, Brooks DJ, Brezing CA, et al. Mixed amphetamine salts–extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial. Experimental and Clinical Psychopharmacology. 2024;32(1):112-127. doi:10.1037/pha0000676

BibTeX
@article{Carpenter2024,
  author = {Carpenter, Kenneth M and Choi, C Jean and Basaraba, Cale and Pavlicova, Martina and Brooks, Daniel J and Brezing, Christina A and Bisaga, Adam and Nunes, Edward V and Mariani, John J and Levin, Frances R},
  title = {Mixed amphetamine salts–extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2024},
  volume = {32},
  number = {1},
  pages = {112--127},
  doi = {10.1037/pha0000676}
}
Start for free →